Company news
HeartSciences Inc. news in 2024
HeartSciences Inc.'s news releases, calls and decks from 2024, newest first.
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
December 15, 2024
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
November 12, 2024
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
September 11, 2024
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
September 11, 2024
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
July 28, 2024
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
July 24, 2024
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 10, 2024
HeartSciences Regains Compliance with Nasdaq Listing Requirements
June 3, 2024
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
May 19, 2024
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
April 23, 2024
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
March 25, 2024
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
March 13, 2024
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
March 11, 2024
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
March 5, 2024
HeartSciences Adds Key Advisor to its Scientific Advisory Board
February 25, 2024
HeartSciences Expands its Scientific Advisory Board
February 11, 2024
HeartSciences Appoints New Scientific Advisory Board Member
January 31, 2024
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
January 17, 2024